Wave Life Sciences WVE Estimates

NASDAQ WVE
$4.88 +0.18 (+3.83%)
As of: Sep 4, 2026 · 11:47 AM EDT
Analyst Estimates

Wave Life Sciences, Inc. Revenue Estimates

Periods 26
Next Period Q3 26
Consensus 5.94 M

Analysts expect Wave Life Sciences, Inc. to report revenue of 5.94 M for Q3 26, against a range of 5.39 M to 6.49 M. The most recent reported quarter, Q2 26, came in at 2.27 M, a 67.8% miss against the 7.06 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -7.68 M83.75 M9.18 M8.70 M7.61 M17.24 M38.25 M2.27 M--------
High Estimate 16.78 M27.71 M13.59 M13.02 M14.22 M17.61 M8.58 M7.37 M6.49 M7.13 M4.34 M4.04 M6.74 M11.55 M13.62 M11.90 M
Low Estimate 14.24 M26.04 M11.47 M11.82 M12.28 M15.16 M7.77 M6.74 M5.39 M6.65 M4.00 M3.44 M6.31 M9.87 M12.43 M10.07 M
Consensus Estimate 15.51 M26.87 M12.53 M12.42 M13.25 M16.38 M8.18 M7.06 M5.94 M6.89 M4.17 M3.74 M6.53 M10.71 M13.02 M10.99 M
Analyst Estimates

Wave Life Sciences, Inc. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus -0.33

Analysts expect Wave Life Sciences, Inc. to report earnings per share of -0.33 for Q3 26, against a range of -0.36 to -0.30. The most recent reported quarter, Q2 26, came in at -0.34, a 17.2% miss against the -0.29 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.470.18-0.29-0.31-0.32-0.30-0.13-0.34--------
High Estimate -0.29-0.16-0.25-0.28-0.29-0.25-0.30-0.26-0.30-0.33-0.36-0.37-0.36-0.31-0.29-0.35
Low Estimate -0.31-0.18-0.29-0.32-0.35-0.27-0.32-0.32-0.36-0.35-0.40-0.45-0.38-0.35-0.31-0.41
Consensus Estimate -0.30-0.17-0.27-0.30-0.32-0.26-0.31-0.29-0.33-0.34-0.38-0.41-0.37-0.33-0.30-0.38